Literature DB >> 20615475

Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.

Janet H Kim1, Joanna M Schaenman, Dora Y Ho, Janice M Y Brown.   

Abstract

Infection because of herpes simplex virus (HSV) that is resistant to acyclovir (ACV) poses treatment challenges in hematopoietic cell transplant (HCT) patients. We present a series of patients with ACV-resistant HSV following HCT who were successfully treated with continuous infusion high-dose ACV after failing standard treatment regimens for ACV-resistant HSV.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20615475     DOI： 10.1016/j.bbmt.2010.06.020

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  6 in total

1.  Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.

Authors:  Joshua T Schiffer; David A Swan; Lawrence Corey; Anna Wald
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

Review 2.  A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.

Authors:  Sharon Elad; Vinisha Ranna; Anura Ariyawardana; Maria Elvira Pizzigatti Correa; Vanessa Tilly; Raj G Nair; Tanya Rouleau; Richard M Logan; Andres Pinto; Veronica Charette; Debbie P Saunders; Siri Beier Jensen
Journal:  Support Care Cancer       Date:  2016-11-16       Impact factor: 3.603

3.  Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly; Lokesh R Shahani; Ying Jang; Richard E Champlin; Victor E Mulanovich
Journal:  Transpl Int       Date:  2018-03-13       Impact factor: 3.782

4.  Viral Venereal Diseases of the Skin.

Authors:  Theodora K Karagounis; Miriam K Pomeranz
Journal:  Am J Clin Dermatol       Date:  2021-05-18       Impact factor: 7.403

Review 5.  Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.

Authors:  Christine Johnston; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

6.  Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients.

Authors:  Natalia Maximova; Daniela Nisticò; Giacomo Luci; Roberto Simeone; Elisa Piscianz; Ludovica Segat; Egidio Barbi; Antonello Di Paolo
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.